Gout is the form of arthritis characterized by crystal deposits in and around the joints. Specifically, needle-shaped crystals of monosodium urate accumulate in joint tissue and trigger intense inflammatory attacks. A related but distinct condition called calcium pyrophosphate deposition disease (often called pseudogout) also involves crystal deposits, though the crystal type, location, and pattern differ significantly from gout.
How Urate Crystals Form in Gout
Uric acid is the final product of purine metabolism in humans. Unlike most other animals, which break purines down into a more soluble substance, humans are left with uric acid, a poorly soluble compound. Under normal conditions, uric acid circulates in the blood in an ionic form called urate. When urate levels climb too high, it combines with sodium to form monosodium urate, a salt that is even less soluble. Once the concentration exceeds what the fluid in and around your joints can hold in solution, crystals begin to precipitate.
These crystals have a distinctive needle-like shape. Under a microscope, stacked sheets of purine rings form their long axis, and their surfaces are rich in charged oxygen atoms and sodium ions. That ionic surface is what makes them so inflammatory: it interacts directly with cell membranes and blood proteins, essentially sounding an alarm that draws immune cells to the area.
When crystals land in a joint, they activate resident immune cells called macrophages, which release powerful inflammatory signals. This triggers a flood of neutrophils, the first-responder white blood cells responsible for the redness, heat, swelling, and severe pain of an acute gout flare. The neutrophils themselves get further activated by the crystals they encounter, amplifying the inflammatory cascade.
Who Gets Gout and Why
About two-thirds of the uric acid in your body is produced internally, mainly in the liver. The remaining third comes from dietary purines. Blood uric acid levels reflect the balance between how much you produce and how efficiently your kidneys excrete it. Anything that tips that balance toward accumulation raises the risk of crystal formation.
On the dietary side, high-purine foods like organ meats, certain seafood, and legumes contribute to uric acid production. Alcohol and sugar-sweetened beverages also raise levels. The rising prevalence of overweight and obesity is closely linked to the progressive increase in uric acid levels seen across populations.
Certain medications are a significant and often overlooked trigger. Diuretics, commonly prescribed for high blood pressure and heart failure, increase uric acid in two ways: they cause fluid loss that concentrates uric acid in the blood, and they alter transport proteins in the kidneys to increase uric acid reabsorption. Beta-blockers can reduce blood flow through the kidneys, lowering the filtration rate and allowing uric acid to build up. If you take blood pressure medication and develop joint symptoms, the connection is worth exploring with your doctor.
Where Gout Strikes
Gout has a strong preference for the base of the big toe, the joint where the toe connects to the foot. This joint is the classic first target, and a sudden, excruciating flare there is one of the most recognizable presentations in medicine. Gout can also affect ankles, knees, wrists, fingers, and elbows, but the big toe remains the hallmark.
Without treatment, gout progresses. Early on, flares come and go with symptom-free intervals. Over time, chronically elevated uric acid leads to larger, more permanent crystal deposits called tophi. These chalky lumps form in and around joints, tendons, and even bones. On X-rays, they produce a characteristic pattern of bone erosion with “overhanging edges,” a finding highly specific to gout. Tophaceous gout can cause lasting joint damage and deformity.
Pseudogout: The Other Crystal Arthritis
Calcium pyrophosphate deposition disease, commonly called pseudogout, involves a completely different crystal. Instead of urate, the culprit is calcium pyrophosphate, which forms when a byproduct of energy metabolism in cartilage cells combines with calcium ions. These crystals deposit primarily in cartilage rather than in the joint fluid or soft tissue.
Pseudogout tends to hit different joints than gout. The knees are the most common site, followed by wrists, shoulders, hips, and elbows. It rarely affects the big toe. The inflammatory mechanism shares some overlap with gout, activating the same core immune pathway, but the clinical picture and treatment approach differ.
How Doctors Tell Them Apart
The gold standard for diagnosing crystal arthritis is examining fluid drawn from the affected joint under a polarizing microscope. The two crystal types look distinctly different. Gout crystals appear as bright yellow, fine, needle-shaped structures that bend light in a specific direction (called negative birefringence). Pseudogout crystals are rhomboid, meaning diamond-shaped, and bend light in the opposite direction (positive birefringence). These visual differences make a definitive diagnosis possible in most cases.
Joint aspiration does have limitations. In about 25% of acute gout cases, the fluid sample comes back negative for crystals. When the affected joint is hard to access, when there isn’t enough fluid to draw, or when crystals are deposited in tendons and other tissues outside the joint itself, a specialized imaging technique called dual-energy CT can help. This scan can detect urate deposits noninvasively, with studies showing sensitivity around 87 to 90% and specificity around 83 to 84% compared to microscopy. It’s particularly useful for identifying crystal deposits in places a needle can’t easily reach.
Managing Uric Acid Levels Long-Term
Treating a gout flare addresses the immediate pain and inflammation, but the long-term goal is lowering uric acid enough to dissolve existing crystals and prevent new ones from forming. Current guidelines from the American College of Rheumatology recommend keeping serum uric acid below 6 mg/dL for all gout patients. European guidelines set an even lower target of below 5 mg/dL for people who already have tophi, chronic joint damage, or frequent flares, since a lower level speeds up crystal dissolution.
Reaching these targets typically requires urate-lowering medication combined with dietary changes. Reducing high-purine foods, limiting alcohol (especially beer), cutting back on sugary drinks, and maintaining a healthy weight all help lower uric acid. For people whose gout is driven partly by medications like diuretics, adjusting the blood pressure regimen can make a meaningful difference. The crystals that have already formed do dissolve once uric acid stays consistently below the saturation point, but this process takes months to years depending on how large the deposits are.